Opinion
Video
Understanding PIRA in MS: Key Insights and Advances From ECTRIMS 2024
Author(s):
Key Takeaways
- PIRA represents MS progression without clinical relapses, impacting patients' quality of life by contributing to disability accumulation.
- Unlike RAW, PIRA reflects insidious progression, often undetected by traditional relapse-focused assessments.
Panelists discuss how progression independent of relapse activity (PIRA) in multiple sclerosis (MS) represents continuous neurological decline unrelated to inflammatory events, distinct from relapse-associated worsening (RAW). Recent ECTRIMS 2024 presentations emphasized standardized evaluation methods to better understand disease progression and improve patient management strategies.
Video content above is prompted by the following:
- Cognition and PIRA in MS have received a lot of attention in recent years.
- Please provide an overview of PIRA and its potential impact on a patient’s quality of life.
- How is PIRA different from RAW?
- How is PIRA evaluated? Discuss presentations from ECTRIMS 2024 by Muller and others about standardization of PIRA evaluation and why it might matter.
Related Videos
Related Content
